Vedolizumab Intravenous (IV) Compared to Placebo in Chinese Participants With Crohn's Disease.

Clinical trial NCT03234907 · COMPLETED

Trial details

NCT number: NCT03234907
Sponsor: Takeda
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Crohn's Disease

Start date: 2017-08-03
Primary completion: 2020-08-14
Enrollment: 215

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.